EyePoint, Inc. (EYPT) — Stock Score Summary

EyePoint, Inc. (EYPT) has a MoatMap StockRank of 5/100 based on Quality (20/100), Value (29/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL. EyePoint Pharmaceuticals is a clinical-stage biopharmaceutical company. While its drug delivery tech has potential, it is pre-profit and highly speculative, lacking the established cash flows and pricing power required by our investment lenses.

EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing and commercializing innovative therapeutics for serious eye diseases. The company's proprietary Durasert technology provides sustained-release drug delivery, establishing a strong competitive moat in the ocular therapeutics market. It operates as a niche leader in long-acting treatments for retinal diseases like wet age-related macular degeneration.

Key Financial Metrics

Price$11.77
Market Cap$1.1B
P/E (Forward)-4.28
Price/Book30.96
Return on Equity-102.7%
Return on Invested Capital-70.8%
Debt/Equity46.82
Gross Margin0.0%
Operating Margin-450.7%
Revenue Growth161.7%
Free Cash Flow$-169M

EyePoint, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is EyePoint, Inc.’s (EYPT) StockRank?
MoatMap’s StockRank for EyePoint, Inc. (EYPT) is 5/100, with a Strong Sell signal. It is a composite of Quality (20), Value (29), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does EyePoint, Inc. have an economic moat?
EyePoint, Inc. (EYPT) has a Quality factor score of 20/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is EyePoint, Inc. a buy, hold, or sell?
MoatMap’s current signal for EyePoint, Inc. (EYPT) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is EyePoint, Inc. in?
EyePoint, Inc. (EYPT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksEYPT deep dive reportAI ChampionsHow we score stocksSense-check another stock